Home
Medical Imaging
Molecular Imaging
PET/CT Scanners
Biograph PET/CT family for radiation therapy planning

Biograph family for radiation therapy planningSet the standard in PET/CT for RT

The entire Biograph™ PET/CT family supports dedicated solutions for radiation therapy (RT) planning and gives you access to intelligent imaging applications powered by artificial intelligence, driving the right planning for the right treatment.

Features & Benefits

Set the standard in PET/CT for RT

Our Biograph family offers RT editions that deliver dedicated tools for precise planning with dose optimization and time savings. Additionally, Biograph mCT Sim edition and Biograph Vision™ RT Pro edition feature a large bore (78 cm) to ensure patient comfort and better positioning reproducibility.

artificial intelligence application in nuclear medicine - AIDAN Intelligent imaging platform for PET CT scan machiness.

Intelligent imaging with AIDAN

Enabled by AIDAN, the Biograph family uses intelligent imaging applications to transform complex procedures and make standardized protocols and personalized scans possible.

Learn more about AIDAN

Clinical decision making

Molecular imaging can help answer clinical questions that might not be answered using anatomical imaging alone. PET/CT provides a combination of metabolic and morphological information, which has a major impact on evaluation and therapy planning of primary and recurrent tumors.

The Biograph family with RT edition offers an integrated workflow, enabled by syngo.via®³, that supports clinical decisions along with a multi-modality tool for deformable registration, dose visualization, beam placement, and more.

Learn more about syngo.via for MI

Clinical use

Clincal image review

Data courtesy of University of Tennessee Medical Center, Knoxville, Tennessee, USA.

FlowMotion enables targeted respiratory gating for improved SBRT planning in a patient with lung cancer

Malignant lung nodule sharply defined with ultraHD•PET with high lesion contrast allows target planning for sterotactic body radiation therapy (SBRT) for delivering high radiation doses in just a few fractions for enhanced local control and lower toxicity
Incorporation of respiratory gating and HD•Chest into FlowMotion™ continuous-bed-motion acquisition enables definition of lesion motion for appropriate target definition

PET – Biograph mCT Flow™
Image reconstruction
200 x 200 matrix, PSF+TOF 3i21s Gaussian filter 5

Scan time
FlowMotion continuous bed motion
1.5 mm/s head 0.4 mm/s thorax (gated)
1.5 mm/s abdomen and pelvis
Total scan time: 10 minutes

Injected dose
Fludeoxyglucose F 18 (¹⁸F FDG) Injection 9 mCi (333 MBq)

CT
Scan parameters
120 kV/100 ref mAs

Data courtesy of Keio University Hospital, Tokyo, Japan.

PET/CT helps delineation of radiotherapy target volume with implication for dose escalation in rectal cancer

¹⁸F FDG PET/CT delineates large, hypermetabolic rectal carcinoma with small solitary hypermetabolic presacral lymph node
The radiation therapy plan was altered in order to include the solitary presacral node in the gross tumor volume (GTV)
Total dose prescribed was 54 Gy to GTV at 1.8 Gy per fraction with dose escalation to the area with highest tracer uptake

PET – Biograph mCT
Image reconstruction
200 x 200 matrix, PSF+TOF 3i21s

Scan time
7 bed positions/3 min per bed
Total scan time: 21 minutes

Injected dose
Fludeoxyglucose F 18 (¹⁸F FDG) Injection
10 mCi (370 MBq)

CT
Scan parameters
120 kV/57 ref mAs

Data courtesy of University of Tennessee Medical Center, Knoxville, Tennessee, USA.

FlowMotion enables targeted respiratory gating for improved SBRT planning in a patient with lung cancer

Malignant lung nodule sharply defined with ultraHD•PET with high lesion contrast allows target planning for sterotactic body radiation therapy (SBRT) for delivering high radiation doses in just a few fractions for enhanced local control and lower toxicity
Incorporation of respiratory gating and HD•Chest into FlowMotion™ continuous-bed-motion acquisition enables definition of lesion motion for appropriate target definition

PET – Biograph mCT Flow™
Image reconstruction
200 x 200 matrix, PSF+TOF 3i21s Gaussian filter 5

Scan time
FlowMotion continuous bed motion
1.5 mm/s head 0.4 mm/s thorax (gated)
1.5 mm/s abdomen and pelvis
Total scan time: 10 minutes

Injected dose
Fludeoxyglucose F 18 (¹⁸F FDG) Injection 9 mCi (333 MBq)

CT
Scan parameters
120 kV/100 ref mAs

Data courtesy of Keio University Hospital, Tokyo, Japan.

PET/CT helps delineation of radiotherapy target volume with implication for dose escalation in rectal cancer

¹⁸F FDG PET/CT delineates large, hypermetabolic rectal carcinoma with small solitary hypermetabolic presacral lymph node
The radiation therapy plan was altered in order to include the solitary presacral node in the gross tumor volume (GTV)
Total dose prescribed was 54 Gy to GTV at 1.8 Gy per fraction with dose escalation to the area with highest tracer uptake

PET – Biograph mCT
Image reconstruction
200 x 200 matrix, PSF+TOF 3i21s

Scan time
7 bed positions/3 min per bed
Total scan time: 21 minutes

Injected dose
Fludeoxyglucose F 18 (¹⁸F FDG) Injection
10 mCi (370 MBq)

CT
Scan parameters
120 kV/57 ref mAs

Data courtesy of University of Tennessee Medical Center, Knoxville, Tennessee, USA.

FlowMotion enables targeted respiratory gating for improved SBRT planning in a patient with lung cancer

Malignant lung nodule sharply defined with ultraHD•PET with high lesion contrast allows target planning for sterotactic body radiation therapy (SBRT) for delivering high radiation doses in just a few fractions for enhanced local control and lower toxicity
Incorporation of respiratory gating and HD•Chest into FlowMotion™ continuous-bed-motion acquisition enables definition of lesion motion for appropriate target definition

PET – Biograph mCT Flow™
Image reconstruction
200 x 200 matrix, PSF+TOF 3i21s Gaussian filter 5

Scan time
FlowMotion continuous bed motion
1.5 mm/s head 0.4 mm/s thorax (gated)
1.5 mm/s abdomen and pelvis
Total scan time: 10 minutes

Injected dose
Fludeoxyglucose F 18 (¹⁸F FDG) Injection 9 mCi (333 MBq)

CT
Scan parameters
120 kV/100 ref mAs

The outcomes achieved by the Siemens Healthineers customers described herein were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (eg, hospital size, case mix, level of IT adoption) there can be no guarantee that others will achieve the same results.

Please see Indications and Important Safety Information for Fludeoxyglucose F 18 (¹⁸F FDG) Injection and full Prescribing Information.

Our PET/CT scanners

Learn more about Molecular Imaging

Our complete portfolio

Not available for Biograph Horizon RT edition.

Optional. Requires a gating device that can trigger the CT scanner (such as Anzai/RGSC). The outcomes achieved by the Siemens Healthineers customers described herein were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (eg, hospital size, case mix, level of IT adoption) there can be no guarantee that others will achieve the same results.

Subscribe to news from Siemens Healthineers UK and Ireland

Keep up to date on the latest trends in healthcare. Read about current developments, new products and upcoming events.